The agreement is to redesign the medical device approval process and eliminate cumbersome and unnecessary steps. Jeffrey Shuren, director of the Center for Devices and Radiological Health at FDA, told the North County Times that the FDA is looking for similar arrangements with trade groups across the country.
Related Articles on Medical Devices:
Covidien Elects President and CEO Jose E. Almeida Chairman of the Board
Investment in Medical Device and Biotech Firms Hit 15-Year Low in 2011
Breast Implant Recall Raises Questions About CE Mark Approval Process
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.